The more we extend our horizon, the more likely it is that stocks will provide juicy returns. Leading drugmaker Amgen could have several growth drivers through the end of the decade. Tepezza remains ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Three-time Major Champion Pádraig Harrington and PGA TOUR winner Séamus Power have confirmed they will be joining Rory McIlroy and Shane Lowry at the 2025 Amgen Irish Open.

Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

Connor Clark & Lunn Investment Management Ltd. significantly increased its holdings in Amgen Inc. by 89.2% in the 4th quarter ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

In the latest trading session, Amgen (AMGN) closed at $317.17, marking a +1.1% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.64%. Meanwhile, the Dow experienced a rise ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...